Other studies revealed cases of patients previously diagnosed with headaches whose characteristics changed after receiving IFN-β treatment which led to reconsideration of the initial diagnosis from tension-type cephalalgic syndrome to migraines without aura [20]. Here, IFNB1 is linked to migraine disorder.